Home › Obsessive-Compulsive Disorder › NCT03826693
Efficacy of Nitrous Oxide in OCD: Pilot Study
RecruitingPhase 2
Who can join
Ages 18 to 65 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 18-65 * Primary diagnosis of OCD * Sufficient severity of OCD symptoms * Ability to tolerate a treatment-free period * Capacity to provide informed consent Exclusion Criteria: * Psychiatric or medical conditions that make participation unsafe * Pregnant or nursing females * Concurrent use of any medications that might increase the risk of participation (e.g. drug interactions)
About the study
This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.
What is being tested
- Nitrous Oxide (drug)
- Nitrogen (drug)
Sponsor: Stanford University · Participants: 45 · Started: Apr 17, 2021
Contact the study team
- Pavithra Mukunda, MS · Phone: 650-723-4095
- Sindu Menon, MBBS · Phone: 650-723-4095
Official record on ClinicalTrials.gov — NCT03826693
Locations in the U.S.
| California | Stanford University, Stanford |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.